Found: 1
Select item for more details and to access through your institution.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
- By:
- Publication type:
- Article